Logo image of BSVN

BANK7 CORP (BSVN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BSVN - US06652N1072 - Common Stock

40.95 USD
-0.19 (-0.46%)
Last: 12/29/2025, 8:00:02 PM
42.61 USD
+1.66 (+4.05%)
After Hours: 12/22/2025, 8:00:02 PM
Fundamental Rating

5

Overall BSVN gets a fundamental rating of 5 out of 10. We evaluated BSVN against 388 industry peers in the Banks industry. BSVN has an average financial health and profitability rating. BSVN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BSVN had positive earnings in the past year.
BSVN had a positive operating cash flow in the past year.
In the past 5 years BSVN has always been profitable.
Each year in the past 5 years BSVN had a positive operating cash flow.
BSVN Yearly Net Income VS EBIT VS OCF VS FCFBSVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

BSVN's Return On Assets of 2.29% is amongst the best of the industry. BSVN outperforms 98.45% of its industry peers.
The Return On Equity of BSVN (17.95%) is better than 97.42% of its industry peers.
Industry RankSector Rank
ROA 2.29%
ROE 17.95%
ROIC N/A
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)19.53%
ROE(5y)18.95%
ROIC(3y)N/A
ROIC(5y)N/A
BSVN Yearly ROA, ROE, ROICBSVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of BSVN (45.01%) is better than 98.20% of its industry peers.
In the last couple of years the Profit Margin of BSVN has grown nicely.
The Operating Margin and Gross Margin are not available for BSVN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 45.01%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y3.96%
PM growth 5Y19.91%
GM growth 3YN/A
GM growth 5YN/A
BSVN Yearly Profit, Operating, Gross MarginsBSVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

BSVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BSVN has more shares outstanding
The number of shares outstanding for BSVN has been reduced compared to 5 years ago.
There is no outstanding debt for BSVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BSVN Yearly Shares OutstandingBSVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BSVN Yearly Total Debt VS Total AssetsBSVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BSVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC8.78%
BSVN Yearly LT Debt VS Equity VS FCFBSVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BSVN Yearly Current Assets VS Current LiabilitesBSVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

BSVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.21%, which is quite good.
BSVN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.98% yearly.
BSVN shows a decrease in Revenue. In the last year, the revenue decreased by -4.90%.
Measured over the past years, BSVN shows a quite strong growth in Revenue. The Revenue has been growing by 17.51% on average per year.
EPS 1Y (TTM)19.21%
EPS 3Y23.81%
EPS 5Y42.98%
EPS Q2Q%-8.87%
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y20.65%
Revenue growth 5Y17.51%
Sales Q2Q%1.37%

3.2 Future

Based on estimates for the next years, BSVN will show a decrease in Earnings Per Share. The EPS will decrease by -2.13% on average per year.
BSVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.85% yearly.
EPS Next Y-6.78%
EPS Next 2Y-5.97%
EPS Next 3Y-2.13%
EPS Next 5YN/A
Revenue Next Year0.45%
Revenue Next 2Y1.33%
Revenue Next 3Y2.85%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BSVN Yearly Revenue VS EstimatesBSVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
BSVN Yearly EPS VS EstimatesBSVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.04, which indicates a very decent valuation of BSVN.
89.43% of the companies in the same industry are more expensive than BSVN, based on the Price/Earnings ratio.
BSVN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.84.
Based on the Price/Forward Earnings ratio of 9.57, the valuation of BSVN can be described as reasonable.
Based on the Price/Forward Earnings ratio, BSVN is valued a bit cheaper than the industry average as 64.43% of the companies are valued more expensively.
BSVN is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.40, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.04
Fwd PE 9.57
BSVN Price Earnings VS Forward Price EarningsBSVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BSVN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BSVN is cheaper than 76.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.56
EV/EBITDA N/A
BSVN Per share dataBSVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

A cheap valuation may be justified as BSVN's earnings are expected to decrease with -2.13% in the coming years.
PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2Y-5.97%
EPS Next 3Y-2.13%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.64%, BSVN has a reasonable but not impressive dividend return.
BSVN's Dividend Yield is comparable with the industry average which is at 2.74.
Compared to an average S&P500 Dividend Yield of 2.00, BSVN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.64%

5.2 History

The dividend of BSVN is nicely growing with an annual growth rate of 73.25%!
BSVN has been paying a dividend for over 5 years, so it has already some track record.
BSVN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)73.25%
Div Incr Years4
Div Non Decr Years4
BSVN Yearly Dividends per shareBSVN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BSVN pays out 20.81% of its income as dividend. This is a sustainable payout ratio.
DP20.81%
EPS Next 2Y-5.97%
EPS Next 3Y-2.13%
BSVN Yearly Income VS Free CF VS DividendBSVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BSVN Dividend Payout.BSVN Dividend Payout, showing the Payout Ratio.BSVN Dividend Payout.PayoutRetained Earnings

BANK7 CORP

NASDAQ:BSVN (12/29/2025, 8:00:02 PM)

After market: 42.61 +1.66 (+4.05%)

40.95

-0.19 (-0.46%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-15 2025-10-15/bmo
Earnings (Next)01-14 2026-01-14/bmo
Inst Owners35.7%
Inst Owner Change3.34%
Ins Owners6.57%
Ins Owner Change0.26%
Market Cap386.98M
Revenue(TTM)96.41M
Net Income(TTM)43.39M
Analysts80
Price Target53.72 (31.18%)
Short Float %1.19%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield 2.64%
Yearly Dividend0.87
Dividend Growth(5Y)73.25%
DP20.81%
Div Incr Years4
Div Non Decr Years4
Ex-Date12-22 2025-12-22 (0.27)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.89%
Min EPS beat(2)4.06%
Max EPS beat(2)13.73%
EPS beat(4)4
Avg EPS beat(4)7.27%
Min EPS beat(4)4.06%
Max EPS beat(4)13.73%
EPS beat(8)8
Avg EPS beat(8)13.35%
EPS beat(12)10
Avg EPS beat(12)8.05%
EPS beat(16)11
Avg EPS beat(16)5.82%
Revenue beat(2)2
Avg Revenue beat(2)4.96%
Min Revenue beat(2)4.38%
Max Revenue beat(2)5.54%
Revenue beat(4)3
Avg Revenue beat(4)2.2%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)5.54%
Revenue beat(8)6
Avg Revenue beat(8)4.94%
Revenue beat(12)8
Avg Revenue beat(12)3.2%
Revenue beat(16)10
Avg Revenue beat(16)2.75%
PT rev (1m)0%
PT rev (3m)-0.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.1%
EPS NY rev (1m)0%
EPS NY rev (3m)1.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2%
Valuation
Industry RankSector Rank
PE 9.04
Fwd PE 9.57
P/S 4.01
P/FCF 8.56
P/OCF 7.71
P/B 1.6
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)4.53
EY11.06%
EPS(NY)4.28
Fwd EY10.45%
FCF(TTM)4.78
FCFY11.68%
OCF(TTM)5.31
OCFY12.96%
SpS10.2
BVpS25.58
TBVpS24.31
PEG (NY)N/A
PEG (5Y)0.21
Graham Number51.06
Profitability
Industry RankSector Rank
ROA 2.29%
ROE 17.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 45.01%
GM N/A
FCFM 46.89%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)19.53%
ROE(5y)18.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y3.96%
PM growth 5Y19.91%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 461.15%
Cap/Sales 5.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 104.18%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)211.77%
Cap/Depr(5y)146.78%
Cap/Sales(3y)2.6%
Cap/Sales(5y)1.96%
Profit Quality(3y)136%
Profit Quality(5y)132.69%
High Growth Momentum
Growth
EPS 1Y (TTM)19.21%
EPS 3Y23.81%
EPS 5Y42.98%
EPS Q2Q%-8.87%
EPS Next Y-6.78%
EPS Next 2Y-5.97%
EPS Next 3Y-2.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y20.65%
Revenue growth 5Y17.51%
Sales Q2Q%1.37%
Revenue Next Year0.45%
Revenue Next 2Y1.33%
Revenue Next 3Y2.85%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.68%
FCF growth 3Y20.09%
FCF growth 5Y25.89%
OCF growth 1Y17.38%
OCF growth 3Y22.48%
OCF growth 5Y23.47%

BANK7 CORP / BSVN FAQ

What is the ChartMill fundamental rating of BANK7 CORP (BSVN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BSVN.


What is the valuation status for BSVN stock?

ChartMill assigns a valuation rating of 5 / 10 to BANK7 CORP (BSVN). This can be considered as Fairly Valued.


What is the profitability of BSVN stock?

BANK7 CORP (BSVN) has a profitability rating of 5 / 10.


How financially healthy is BANK7 CORP?

The financial health rating of BANK7 CORP (BSVN) is 4 / 10.


Can you provide the expected EPS growth for BSVN stock?

The Earnings per Share (EPS) of BANK7 CORP (BSVN) is expected to decline by -6.78% in the next year.